Fresenius Medical Care AG & Co. KGAA (FME) Receives Average Rating of “Hold” from Analysts

Shares of Fresenius Medical Care AG & Co. KGAA (ETR:FME) have received an average recommendation of “Hold” from the nineteen research firms that are currently covering the company, Marketbeat reports. One equities research analyst has rated the stock with a sell rating, eight have given a hold rating and ten have given a buy rating to the company. The average 12 month target price among analysts that have issued a report on the stock in the last year is €89.05 ($104.77).

A number of analysts recently issued reports on the company. S&P Global set a €95.00 ($111.76) target price on Fresenius Medical Care AG & Co. KGAA and gave the company a “buy” rating in a research report on Monday, November 6th. Credit Suisse Group set a €92.00 ($108.24) target price on Fresenius Medical Care AG & Co. KGAA and gave the company a “buy” rating in a research report on Monday, November 6th. HSBC Holdings PLC set a €85.00 ($100.00) target price on Fresenius Medical Care AG & Co. KGAA and gave the company a “neutral” rating in a research report on Wednesday. Goldman Sachs Group, Inc. (The) set a €97.00 ($114.12) target price on Fresenius Medical Care AG & Co. KGAA and gave the company a “buy” rating in a research report on Monday, November 6th. Finally, Deutsche Bank AG set a €83.00 ($97.65) target price on Fresenius Medical Care AG & Co. KGAA and gave the company a “neutral” rating in a research report on Friday, November 3rd.

Fresenius Medical Care AG & Co. KGAA (ETR:FME) traded down €0.20 ($0.24) during trading hours on Thursday, hitting €82.50 ($97.06). The company had a trading volume of 381,996 shares, compared to its average volume of 515,915. Fresenius Medical Care AG & Co. KGAA has a twelve month low of €71.49 ($84.11) and a twelve month high of €89.22 ($104.96).

ILLEGAL ACTIVITY WARNING: This news story was first reported by Community Financial News and is owned by of Community Financial News. If you are reading this news story on another website, it was stolen and reposted in violation of international trademark & copyright laws. The original version of this news story can be read at https://www.com-unik.info/2017/11/23/fresenius-medical-care-ag-co-kgaa-fme-receives-average-rating-of-hold-from-analysts.html.

Fresenius Medical Care AG & Co. KGAA Company Profile

Fresenius Medical Care AG & Co KGaA, a kidney dialysis company, provides dialysis care and related services, and other health care services. It offers dialysis treatment, and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized ESRD patients and for patients suffering from acute kidney failure.

Analyst Recommendations for Fresenius Medical Care AG & Co. KGAA (ETR:FME)

What are top analysts saying about Fresenius Medical Care AG & Co. KGAA? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Fresenius Medical Care AG & Co. KGAA and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit